DD vs EMN vs MAGN Stock Comparison

DuPont de Nemours, Eastman Chemical and Magnera Prices as of Nov 13, 2026 Peers: Industry group
DD DuPont de Nemours, Inc.
$153.75 +19.6% 1M +278.7% 1Y
Market cap
$20.11B
P/E
66.8x
Revenue (TTM)
$7.06B
Div. yield
0.02%
Specialty Chemicals Basic Materials
4 wins
EMN Eastman Chemical Co
$65.05 +3.4% 1M +3.7% 1Y
Market cap
$7.22B
P/E
7.9x
Revenue (TTM)
$9.05B
Div. yield
–
Specialty Chemicals Basic Materials
6 wins
MAGN Magnera Corp
$12.62 +19.2% 1M +39.0% 1Y
Market cap
$443.72M
P/E
–
Revenue (TTM)
$3.28B
Div. yield
–
Specialty Chemicals Basic Materials
1 win

Head to Head

11 decided of 12

Eastman Chemical leads on 6 of the 12 questions below (Eastman Chemical 6, DuPont de Nemours 4, Magnera 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionDDEMNMAGNLeader
Larger companyMarket capitalisation $20.11B $7.22B $443.72M DD
Cheaper on earningsLower P/E, profitable companies only 66.8x 7.9x -4.0x EMN
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.1x 10.2x — EMN
Faster revenue growthRevenue growth, trailing twelve months +3.2% +0.3% +12.4% MAGN
More profitableNet margin, trailing twelve months 4.3% 10.1% -3.4% EMN
Better return on capitalReturn on invested capital 4.1% 7.3% 2.2% EMN
Less leveragedLower net debt / EBITDA 0.8x 3.2x 5.1x DD
Higher dividend yieldTrailing dividend yield 0.02% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +278.7% +3.7% +39.0% DD
Better 5-year returnAnnualised price return, 5 years +35.4%/yr -10.9%/yr -44.2%/yr DD
Less volatileAnnualised volatility, 1 year 114.0% 31.6% 55.7% EMN
Higher overall scoreMean of the five percentile scores vs peers 52/100 59/100 54/100 EMN

Percentile Scorecard

DDEMNMAGN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisDDEMNMAGN
Valuation 51 #48 of 96 85 #15 of 96 92 #9 of 96
Growth 37 #58 of 92 22 #72 of 92 96 #5 of 92
Profitability 73 #25 of 89 64 #33 of 89 42 #52 of 89
Financial Health 73 #27 of 96 32 #66 of 96 33 #65 of 96
Shareholder Returns 28 #57 of 79 94 #6 of 79 9 #72 of 79
Overall 52 59 54
  • DD ranked among 99 companies in Chemicals
  • EMN ranked among 99 companies in Chemicals
  • MAGN ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodDDEMNMAGNSPY
1 month +19.6%+3.4%+19.2% -2.0%
3 months +5.1%-12.2%+1.1% -2.8%
6 months +211.8%-9.1%+27.0% +2.0%
Year to date +282.5%+1.9%-16.6% +10.6%
1 year +278.7%+3.7%+39.0% +12.2%
3 years +422.1%-18.5%-34.8% +68.1%
3 years, per year +73.5%-6.6%-13.3% +18.9%
5 years +355.3%-43.9%-94.6% +61.4%
5 years, per year +35.4%-10.9%-44.2% +10.1%
10 years +381.2%-13.5%-95.5% +248.5%
10 years, per year +17.0%-1.4%-26.6% +13.3%

Risk

MeasureDDEMNMAGNSPY
Volatility, 1Y 114.0%31.6%55.7% 13.6%
Downside volatility, 1Y 26.9%29.8%47.9% 13.9%
Beta vs S&P 500, 1Y 1.550.871.22 1.00
Return / volatility, 1Y 2.440.120.70 0.90
Max drawdown, 5Y -41.1%-55.9%-96.7% -25.4%
From 52-week high -2.0%-20.0%-17.3% -3.2%
52-week high $156.84$81.36$15.26 $779.14
52-week low $37.12$56.37$7.96 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleDDEMNMAGN
P/E now vs peer median 68.6xmedian 23.4x 8.1xmedian 23.4x -4.0xmedian 23.4x
P/S now vs peer median 2.9xmedian 1.3x 0.8xmedian 1.3x 0.1xmedian 1.3x
EV/EBITDA now vs peer median 12.4xmedian 12.7x 8.5xmedian 12.7x 6.6xmedian 12.7x
P/FCF now vs peer median 25.7xmedian 17.0x 15.9xmedian 17.0x 2.1xmedian 17.0x
P/B now vs peer median 1.5xmedian 1.5x 1.2xmedian 1.5x 0.4xmedian 1.5x
PEG now vs peer median -1.18median 1.72 -13.19median 1.72 -0.07median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsDDEMNMAGN
Revenue $7.06B $9.05B $3.28B
Gross profit $2.51B $1.86B $392.00M
Operating income $1.14B $868.00M $63.00M
Net income $311.00M $627.00M -$112.00M
Free cash flow $793.00M $469.00M $215.00M
R&D $169.00M $246.00M –
EPS (diluted) $2.23 $7.93 $-3.12
Cash & equivalents $1.65B $768.00M $280.00M
Total debt $3.09B $5.22B $1.90B
Shares (diluted) 135.10M 115.30M 35.90M
Enterprise value $15.29B $4.53B -$708.28M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricDDEMNMAGN
P/E 68.6x 8.1x -4.0x
P/FCF 25.7x 15.9x 2.1x
P/Operating cash flow 18.0x 8.5x 2.6x
P/S 2.9x 0.8x 0.1x
P/B 1.5x 1.2x 0.4x
P/Tangible book 1.9x 1.4x 0.4x
EV/EBITDA 12.4x 8.5x 6.6x
EV/EBIT 19.2x 13.7x 32.9x
EV/Revenue 3.1x 1.3x 0.6x
EV/FCF 27.5x 25.4x 9.6x
EV/Operating cash flow 19.3x 13.5x 12.1x
PEG (3Y EPS CAGR) -1.18 -13.19 -0.07

Growth

14 metrics
MetricDDEMNMAGN
Revenue growth (1Y) 3.2% 0.3% 12.4%
Revenue CAGR (3Y) -16.8% -1.2% 30.4%
Gross profit growth (1Y) 8.1% -9.7% 24.1%
Gross profit CAGR (3Y) -16.2% -1.9% 43.0%
Operating income growth (1Y) -29.7% -18.2% 425.0%
Operating income CAGR (3Y) -20.5% -1.2% 44.7%
Net income growth (1Y) 141.0% -13.3% -12.0%
Net income CAGR (3Y) -59.6% 2.2% 5.9%
EPS growth (1Y) 140.5% -17.2% -11.1%
EPS CAGR (3Y) -58.4% -0.6% 56.8%
Operating cash flow growth (1Y) 504.7% -12.8% –
Operating cash flow CAGR (3Y) -13.3% -13.9% 126.3%
Free cash flow growth (1Y) 282.7% 18.7% 55.8%
Free cash flow CAGR (3Y) -10.2% -3.8% 90.3%

Profitability

14 metrics
MetricDDEMNMAGN
Gross margin 35.5% 20.6% 11.9%
EBITDA margin 24.9% 15.4% 9.6%
Operating margin 16.1% 9.6% 1.9%
Pretax margin 9.3% 7.2% -3.0%
Net margin 4.3% 10.1% -3.4%
FCF margin 11.2% 5.2% 6.5%
Operating cash flow margin 16.0% 9.7% 5.2%
Return on equity 2.3% 10.0% -10.9%
Return on assets 1.5% 4.1% -2.9%
Return on invested capital 4.1% 7.3% 2.2%
Return on capital employed 6.0% 6.8% 1.9%
Asset turnover 0.3x 0.6x 0.8x
Cash conversion (OCF / net income) 3.6x 1.4x -1.5x
Stock comp / revenue 0.7% – 0.5%

Financial Health

11 metrics
MetricDDEMNMAGN
Debt / assets 14.9% 33.7% 49.6%
Debt / equity 0.2x 0.8x 1.9x
Net debt / EBITDA 0.8x 3.2x 5.1x
Debt / FCF 3.9x 11.1x 8.8x
Liabilities / assets 34.2% 59.0% 73.5%
Equity / assets 65.8% 41.0% 26.5%
Interest coverage 6.3x – 0.4x
Current ratio 2.4x 1.6x 2.4x
Quick ratio 1.7x 0.8x 1.4x
Cash ratio 0.8x 0.3x 0.5x
Altman Z-score 0.74 2.32 1.18

Shareholder Returns

7 metrics
MetricDDEMNMAGN
Dividend yield 3.1% 5.2% –
Net buyback yield -0.6% – -7.5%
Shareholder yield 2.5% 5.2% -7.5%
Payout ratio (earnings) 104.5% – –
Payout ratio (FCF) 41.0% – –
Dividend growth (1Y) -51.8% – –
Dividend CAGR (3Y) -20.5% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusDDEMNMAGN
Forward P/E 22.1xFY2026 10.2xFY2026 –
EPS, next fiscal year $6.96FY2026 $6.39FY2026 –
EPS growth, next FY +38.1%FY2026 +17.9%FY2026 –
EPS growth, the year after +22.4% -4.2% –
Revenue, next fiscal year $7.34BFY2026 $9.46BFY2026 –
Revenue growth, next FY +7.2%FY2026 +8.2%FY2026 –
Revenue growth, the year after +7.7% -3.6% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersDDEMNMAGN
Held by institutions 73.0% 94.1% 100.0%
Institutions holding 1,122 651 177
Change in shares held, QoQ -5.7% -0.1% +0.4%
Institutions buying 1,094 327 94
Institutions selling 27 196 43
Buyers to sellers 40.52 1.67 2.19

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

DDEMNMAGN
DD 1.00 0.15 0.08
EMN 0.15 1.00 0.31
MAGN 0.08 0.31 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, DD, EMN and MAGN?

DuPont de Nemours (DD) is the largest by market capitalisation: DuPont de Nemours (DD) $20.11B, Eastman Chemical (EMN) $7.22B, Magnera (MAGN) $443.72M.

Which stock is cheaper, DD, EMN and MAGN?

Eastman Chemical (EMN) trades on the lowest price-to-earnings ratio (DuPont de Nemours (DD) 66.8x, Eastman Chemical (EMN) 7.9x, Magnera (MAGN) -4.0x). On next year's consensus earnings, Eastman Chemical (EMN) is cheapest (DuPont de Nemours (DD) 22.1x, Eastman Chemical (EMN) 10.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Magnera (MAGN) grew revenue fastest over the trailing twelve months: DuPont de Nemours (DD) +3.2%, Eastman Chemical (EMN) +0.3%, Magnera (MAGN) +12.4%.

Which company is more profitable?

Eastman Chemical (EMN) has the highest net margin (DuPont de Nemours (DD) 4.3%, Eastman Chemical (EMN) 10.1%, Magnera (MAGN) -3.4%). On return on invested capital, Eastman Chemical (EMN) leads (DuPont de Nemours (DD) 4.1%, Eastman Chemical (EMN) 7.3%, Magnera (MAGN) 2.2%).

Which stock has performed better?

Over the past year DuPont de Nemours (DD) returned the most: DuPont de Nemours (DD) +278.7%, Eastman Chemical (EMN) +3.7%, Magnera (MAGN) +39.0%. Over five years, DuPont de Nemours (DD) compounded fastest (DuPont de Nemours (DD) +35.4%/yr, Eastman Chemical (EMN) -10.9%/yr, Magnera (MAGN) -44.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: DuPont de Nemours (DD) 0.02%, Eastman Chemical (EMN) 0.00%, Magnera (MAGN) 0.00%. Eastman Chemical (EMN) and Magnera (MAGN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Eastman Chemical (EMN) has been the steadiest (DuPont de Nemours (DD) 114.0%, Eastman Chemical (EMN) 31.6%, Magnera (MAGN) 55.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, DD, EMN and MAGN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Eastman Chemical (EMN) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.